The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.

FREE RADICAL RESEARCH, published by TAYLOR & FRANCIS LTD, stands at the forefront of studies in biochemistry and medicine, with a distinguished trajectory since its inception in 1985. This esteemed journal, which boasts an ISSN of 1071-5762 and an E-ISSN of 1029-2470, is recognized for its impactful contributions within the scientific community, as evidenced by its Q2 ranking in the 2023 category quartiles for both Biochemistry and miscellaneous Medicine. Utilizing rigorous peer-review standards, FREE RADICAL RESEARCH disseminates critical findings on the role of free radicals in biological systems, facilitating knowledge exchange among researchers, healthcare professionals, and students. Although it is not an open-access journal, its reach through academic databases ensures visibility and accessibility of groundbreaking research, making it an indispensable resource for those engaged in the dynamic fields of biochemistry and molecular biology. As the journal continues to evolve until 2024, it remains committed to advancing our understanding of oxidative stress and its implications for health and disease.

ANTIOXIDANTS & REDOX SIGNALING, published by MARY ANN LIEBERT, INC, is a premier journal dedicated to advancing the understanding of oxidative stress, antioxidants, and redox biology in various health contexts. With an impressive track record since its inception in 1999, this journal has continually evolved, currently converging towards 2024 as a core resource for researchers in biochemistry, cell biology, and molecular medicine. It holds a distinguished position in Q1 across several categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, reflecting its critical role in disseminating high-quality research that impacts the fields of physiology and medicine. Despite not being an open-access journal, ANTIOXIDANTS & REDOX SIGNALING is renowned for its rigorous peer-review process and wide reach, ensuring that published articles are both influential and accessible to professionals, academia, and students alike. Researchers can benefit from its comprehensive articles that delve into cutting-edge discoveries and emerging therapies related to oxidative stress and its biological implications.

NEUROTOXICITY RESEARCH is a premier journal published by SPRINGER, focusing on the critical and evolving field of neurotoxicology. With an ISSN of 1029-8428 and an E-ISSN of 1476-3524, this journal serves as a vital platform for researchers, professionals, and students dedicated to understanding the impact of toxic substances on nervous system health. Established in 1999, NEUROTOXICITY RESEARCH has consistently contributed significant findings and discussions that influence both theoretical and applied neuroscience. The journal's impressive Q2 ranking in both Neuroscience (miscellaneous) and Toxicology categories, alongside its strong percentile rankings in Scopus, underscores its relevance and quality in the academic community. While this journal is not open access, it remains a critical resource for those seeking interdisciplinary insights into the mechanisms of neurotoxicity. The objective of NEUROTOXICITY RESEARCH is to elucidate the intricate interactions between environmental and chemical agents and their neurotoxic effects, guiding future research and policies aimed at safeguarding neurological health. Based in the United States at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, this journal is committed to advancing the understanding of neurotoxic mechanisms and fostering collaborative efforts within the scientific community.

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

BIOLOGICAL TRACE ELEMENT RESEARCH, published by SpringerNature, is a prestigious academic journal dedicated to advancing the understanding of trace elements and their critical roles in biological systems. With an impressive range of quartile rankings across multiple disciplines—including Q1 in Inorganic Chemistry and Q2 across various medical and biochemical categories—this journal stands out in its field. Since its inception in 1979, it has provided a vital platform for researchers worldwide to disseminate innovative findings that enhance our knowledge of trace elements in relation to health, environment, and medicine. The journal’s impact is reflected in its notable Scopus rankings, positioning it within the top echelons of biochemistry and medicine. Although primarily a subscription-based publication, it remains an essential resource for professionals, educators, and students alike, seeking to deepen their understanding of the complexities associated with trace elements.

MITOCHONDRION is a distinguished peer-reviewed journal published by Elsevier Science Ltd, focusing on the intricate roles of mitochondria in various biological processes. With an ISSN of 1567-7249 and an E-ISSN of 1872-8278, this journal has carved out a significant niche within the fields of Cell Biology, Molecular Biology, and Molecular Medicine, as evidenced by its Q2 ranking in these categories for 2023. The journal emphasizes the latest research on mitochondrial biogenesis, function, and dynamics, making it a pivotal resource for professionals, researchers, and students engaged in cutting-edge mitochondrial studies. With a robust Scopus ranking, placing it in the top percentiles of its categories, MITOCHONDRION not only advances scientific understanding but also fosters collaboration and innovation within the research community. Though it does not offer Open Access, the journal's comprehensive articles and reviews remain indispensable for those striving to unravel the mysteries of mitochondrial biology. For research spanning from its inception in 2001 through its ongoing commitment to 2024, MITOCHONDRION continues to be a vital platform for disseminating high-quality, impactful research in the realm of mitochondrial science.

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.